feed,title,long_url,short_url
Investors,Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion,https://www.investors.com/news/technology/roche-zealand-pharma-weight-loss-drug-novo-nordisk-cagrisema/,https://da.gd/jBk2P4
